Skip to content

Veracyte VCYT Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$88.01M+32.6%$66.35M+119%$30.32M+15.1%$26.34M-20.3%$33.05M+36.9%
$21.48M+0.3%$21.42M-4.3%$22.37M-2.7%$22.98M-1.1%$23.23M-1.0%
$45.4M+4.1%$43.6M+3.0%$42.33M+5.0%$40.32M+2.9%$39.19M+8.1%
$166.16M+21.9%$136.31M+25.9%$108.25M+15.8%$93.45M+4.5%$89.42M+19.1%
$10.82M+11.8%$9.68M-3.6%$10.04M+5.8%$9.49M-13.5%$10.97M-2.8%
-$108.43M+2.3%-$110.97M-97.2%
$77.03M-37.7%$123.6M
$155.34M+22.7%$126.63M+28.9%$98.21M+17.0%$83.97M+7.0%$78.45M+22.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Veracyte's cash flow data come from?
Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.